SPRO Dividend History & Analysis | N/A Yield
SPRO has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 387,093 M | 3.34% | 7.54% |
| AMGN | 198,244 M | 3.21% | 5.93% |
| GILD | 176,133 M | 2.79% | 5.63% |
| HLN | 46,623 M | 1.76% | 2.46% |
| BIM | 13,627 M | 0.74% | 0.75% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,425 M | 134% | 95.6% |
| HLN | 46,623 M | 30.1% | 100% |
| AMGN | 198,244 M | 7.84% | 100% |
| BIM | 13,627 M | 9.76% | 96.0% |
| ABBV | 387,093 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.21% Yield
2.79% Yield
SPRO Dividend History: as of February 2026
No dividends paid yet.SPRO Dividend FAQ
Spero Therapeutics (NASDAQ: SPRO) is a Cambridge-based clinical-stage biotech that targets multi-drug-resistant bacterial infections and rare diseases in the U.S. Its lead assets are Tebipenem HBr, an oral carbapenem in Phase 3 for complicated urinary-tract infections (including pyelonephritis), and SPR720, a novel oral candidate for first-line treatment of nontuberculous mycobacterial pulmonary disease. The company leverages strategic licenses with Meiji Seika (Tebipenem), Everest Medicines (SPR206 in Greater China, South Korea, and Southeast Asia) and Vertex Pharmaceuticals (patents covering SPR720/SPR719). Founded in 2013, SPRO operates within the Biotechnology sub-industry.
What is the Dividend Yield of SPRO?
As of February 2026, SPRO`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 2.42.Does SPRO pay a dividend?
As of February 2026 SPRO does not pay a dividend.How often does SPRO pay dividends?
Over the last 12 months, SPRO has issued dividend payments.SPRO dividend forecast
Based on historical data, the forecasted dividends per share for SPRO for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will SPRO pay dividends in 2026?
The next Ex-Dividend date for Spero Therapeutics (SPRO) is currently unknown.What is the next Ex-Dividend Date for SPRO?
The next Ex-Dividend date for Spero Therapeutics (SPRO) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of SPRO?
SPRO's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of SPRO?
SPRO's 5-Year Yield on Cost is -%. If you bought SPRO's shares at 21.48 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of SPRO?
SPRO Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does SPRO have a good Dividend Yield?
SPRO`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of SPRO?
The Dividend Payout Ratio of SPRO is unknown.What is the Dividend Rating of SPRO?
SPRO`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-02-01 02:18